Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Astellas Pharma Inc.
  6. Financials
    4503   JP3942400007

ASTELLAS PHARMA INC.

(4503)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: March 2019 2020 2021 2022 2023 2024
Capitalization1 3 186 2313 105 3953 161 4213 543 063--
Entreprise Value (EV)1 2 875 1572 777 5452 829 7333 118 4222 885 9742 862 346
P/E ratio 14,4x16,0x26,2x17,3x14,8x12,6x
Yield 2,29%-2,47%2,55%2,85%3,29%
Capitalization / Revenue 2,44x2,39x2,53x2,68x2,55x2,36x
EV / Revenue 2,20x2,14x2,26x2,36x2,07x1,91x
EV / EBITDA 9,35x8,95x13,6x9,42x7,77x6,77x
Price to Book 2,49x2,41x2,28x2,36x2,22x2,01x
Nbr of stocks (in thousands) 1 921 1521 858 4051 857 4741 853 066--
Reference price (JPY) 1 6591 6711 7021 9121 9121 912
Announcement Date 04/25/201905/14/202004/27/2021---
1 JPY in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net sales1 1 306 3481 300 8431 249 5281 319 6341 391 8481 502 495
EBITDA1 307 370310 387208 703330 906371 467422 743
Operating profit (EBIT)1 243 912243 991136 051259 535299 321347 339
Operating Margin 18,7%18,8%10,9%19,7%21,5%23,1%
Pre-Tax Profit (EBT)1 248 967245 350145 324258 564300 860345 950
Net income1 222 265195 411120 589204 001234 842270 530
Net margin 17,0%15,0%9,65%15,5%16,9%18,0%
EPS2 11510464,9111129152
Dividend per Share2 38,0-42,048,854,563,0
Announcement Date 04/25/201905/14/202004/27/2021---
1 JPY in Million
2 JPY
Income Statement Evolution (Quarterly data)
Fiscal Period: March 2021 S1 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 S1
Net sales1 615 480325 427308 621317 725326 867651 050
EBITDA ------
Operating profit (EBIT)1 86 87272 598-23 41957 47568 633135 900
Operating Margin 14,1%22,3%-7,59%18,1%21,0%20,9%
Pre-Tax Profit (EBT)1 89 09175 136-18 90366 20072 200143 200
Net income1 72 83860 079-12 32852 25056 300113 700
Net margin 11,8%18,5%-3,99%16,4%17,2%17,5%
EPS2 39,232,4-6,6323,930,461,4
Dividend per Share ------
Announcement Date 10/30/202001/29/202104/27/2021---
1 JPY in Million
2 JPY
Previous periodNext period
Balance Sheet Analysis
Fiscal Period: March 2019 2020 2021 2022 2023 2024
Net Debt1 ------
Net Cash position1 311 074327 850331 688424 641657 089680 717
Leverage (Debt / EBITDA) -1,01x-1,06x-1,59x-1,28x-1,77x-1,61x
Free Cash Flow1 233 440-167 795275 459251 339243 924261 421
ROE (Net Profit / Equities) 17,6%15,3%9,00%14,8%16,3%17,6%
Shareholders' equity1 1 262 8691 277 1961 339 8781 379 6121 444 0801 533 195
ROA (Net Profit / Asset) 13,3%11,6%6,33%9,97%11,0%11,8%
Assets1 1 676 5161 678 8581 905 1212 046 8972 142 0942 287 782
Book Value Per Share2 667694748811860952
Cash Flow per Share2 148140104155156170
Capex1 25 19041 26731 38444 57345 51150 847
Capex / Sales 1,93%3,17%2,51%3,38%3,27%3,38%
Announcement Date 04/25/201905/14/202004/27/2021---
1 JPY in Million
2 JPY
Key data
Capitalization (JPY) 3 543 062 803 840
Capitalization (USD) 32 054 633 987
Net sales (JPY) 1 249 528 000 000
Net sales (USD) 11 300 731 232
Number of employees 15 455
Sales / Employee (JPY) 80 849 434
Sales / Employee (USD) 731 202
Free-Float 99,0%
Free-Float capitalization (JPY) 3 505 984 521 696
Free-Float capitalization (USD) 31 719 181 067
Avg. Exchange 20 sessions (JPY) 7 603 297 440
Avg. Exchange 20 sessions (USD) 68 764 222
Average Daily Capital Traded 0,2%
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA